Radiology for liver and biliary diseases is evolving by combining decades of classic imaging expertise with advanced AI tools and emerging microbiome research. From identifying hallmark signs on CT ...

Feasibility study data at 12-22% liver fat cutoffs validate TAEUS as a potential low-cost, point-of-care alternative to MRI-PDFF for patient stratification and trial monitoring ANN ARBOR, ...

I stared at the MRI scan on my computer screen with a mixture of alarm and disbelief. The large pink swathes coating my ...

ENDRA’s TAEUS® Liver Device Demonstrates High-Level Consistency in Clinical Study, Delivering MRI-Level Results at the Point of Patient Care Achieved Intraclass ...

Non-contrast MRI as a surveillance tool for recurrent hepatocellular carcinoma after curative treatment: A prospective multicenter intra-individual comparison trial. First line atezolizumab + ...

Recent advances in CT, MRI, ultrasound, and AI are transforming liver disease diagnosis, enabling earlier, more accurate, and less invasive detection of conditions like fibrosis, steatosis, and ...

PET-CT imaging with [18 F]fluorodeoxyglucose (FDG) and [18 F]fluorocholine (FCH) altered treatment plans in only a tiny minority of patients undergoing initial staging for hepatocellular carcinoma ...

ENDRA Life Sciences NDRA recently announced positive findings from a clinical study assessing the measurement consistency of its TAEUS Liver device. The evaluation demonstrated strong intra-operator ...